Immune Checkpoint Inhibitor-Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study

• Główni autorzy: Li Wang (Autor), Xiaolin Li (Autor), Bin Zhao (Autor), Dan Mei (Autor), Jiandong Jiang (Autor), Jingli Duan (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Introduction: Immune checkpoint inhibitors (ICIs) have substantially improved the clinical outcomes of various malignancies. However, the adverse event of tumor lysis syndrome (TLS) has not been included in the National Comprehensive Cancer Network guidelines or drug inserts. In this study, we aimed...